Skip to content
healthcare.dev

Soliqua 100/33

NDC 0024-5761, insulin glargine and lixisenatide, injection, solution, from Sanofi-Aventis U.S. LLC.

Product NDC
0024-5761
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA208673
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5761 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE100 U/mL
  • LIXISENATIDE33 ug/mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0024-5761-01000245761011 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGE
0024-5761-05000245761055 SYRINGE in 1 CARTON (0024-5761-05) / 3 mL in 1 SYRINGE (0024-5761-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4bba538b-cf7c-4310-ae8f-cb711ed21bcc
  • NADAC price for package 00024576105

    GET /v1/drugs/nadac/00024576105

Use it

Look up 0024-5761 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5761 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0024-5761. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.